Ledger.Open graph →
SEC Form D · filed March 24, 2026

Gilgamesh Pharma Inc

Offering
$60.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Amy Kruse · New York, NYDirectorJonathan Sporn · New York, NYExec · DirectorPhil Skolnick · New York, NYDirectorZia Huque · New York, NYDirectorRobert Berman · New York, NYDirectorAndrew Kruegel · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗